Newsroom
Category
June 17, 2022
An experimental brain injury medication conceived in laboratories at UT Health San Antonio was tested Tuesday, June 14, in the first human subject. If the drug, called AST-004, performs well in human studies, it will be an urgently needed and novel treatment for stroke and traumatic brain injury victims, including those with concussions.
June 14, 2022
This year’s Voelcker Fund Young Investigator Award recipients at UT Health San Antonio are Crystal Archer, PhD, Masahiro Morita, PhD, Neelam Mukherjee, PhD, and Angelina Vaseva, PhD.
June 13, 2022
Ruth Serrano, MD, a physician-scientist and assistant professor in the Division of Infectious Disease in the Department of Medicine in the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio, has a passion and drive to help her patients recover from the profound effects of infectious diseases, including HIV and […]
June 9, 2022
Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have discovered how Vitamin B12 (VB12) can play an integral role in the regulation of host intestinal homeostasis, shaping the gut microbiome health and protecting against pathogenic infections, as found in mouse models. The study, published June 8 in […]
June 6, 2022
In recognition of the U.S. News and World Report’s Best Grad Schools for 2023 rankings, large banners were erected to showcase the Long School of Medicine’s achievement of being named a top 50 medical school for the second year in a row. The banners are located on the facade of the parking garage near the Long School of Medicine on the Long Campus.
June 3, 2022
ERX-41, developed by UT Health San Antonio scientists, exploits a previously unrecognized weakness in breast cancer and other solid tumors. A compound, developed by a team including scientists from The University of Texas Health Science Center at San Antonio, kills a range of hard-to-treat cancer types in petri dishes and animal models by targeting a […]
